Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/002286 stock hub

SHE/002286 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/002286is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.9B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/002286
In the news

Latest news · SHE/002286

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E25.1
P25 23.5P50 41.3P75 83.2
ROE7
P25 -0.9P50 4.1P75 8.8
ROIC7.8
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/002286 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
236
Groups with data
11
Currency
CNY
Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
1,395
Employees Change
179%
Employees Change Percent
14.72
Enterprise value
CNY 3.9B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE100000FL1
Last refreshed
2026-05-10
Market cap
CNY 3.9B
Price
CNY 10.34
Price currency
CNY
Rev Per Employee
2,017,256.22x
Sector
Healthcare
Sic
2090
Symbol
she/002286
Website
https://www.blb-cn.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
3.92%
EV Earnings
25.05x
EV/EBIT
19.3x
EV/EBITDA
11.98x
EV/FCF
68.29x
EV/Sales
1.37x
FCF yield
1.44%
P/B ratio
1.71x
P/E ratio
25.05x
P/S ratio
1.4x
PE Ratio10 Y
55.89x
PE Ratio3 Y
31.62x
PE Ratio5 Y
30.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
7.08%
EBITDA Margin
11.3%
FCF margin
2.01%
Gross margin
13.75%
Gross Profit
CNY 386.8M
Gross Profit Growth
19.44%
Gross Profit Growth Q
23.65%
Gross Profit Growth3 Y
10.5%
Gross Profit Growth5 Y
16.06%
Net Income
CNY 154.4M
Net Income Growth
11.61%
Net Income Growth Q
7.5%
Net Income Growth Quarters
3%
Net Income Growth Years
2%
Net Income Growth3 Y
12.83%
Net Income Growth5 Y
28.15%
Pretax Margin
6.5%
Profit Margin
5.49%
Profit Per Employee
CNY 110,684
Profitable Years
20
ROA
4.38
Roa5y
3.39
ROCE
8.45
ROE
7.03
Roe5y
6.81
ROIC
7.81
Roic5y
7.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr10y
-2.89%
Cagr15y
2.43%
Cagr1y
1.15%
Cagr3y
7.91%
Cagr5y
-1.35%
Div CAGR10
4.7%
Div CAGR3
5.9%
Div CAGR5
9.63%
EPS Growth
8.56
EPS Growth Years
2
EPS Growth3 Y
11.19
EPS Growth5 Y
28.48
FCF Growth
99.37%
FCF Growth3 Y
151.59%
FCF Growth5 Y
-12.35%
OCF Growth
5.27%
OCF Growth10 Y
7.52%
OCF Growth3 Y
15.72%
OCF Growth5 Y
-1.58%
Revenue Growth
10.99x
Revenue Growth Q
9.21x
Revenue Growth Quarters
6x
Revenue Growth Years
1x
Revenue Growth3 Y
1.83x
Revenue Growth5 Y
4.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
CNY 0.99
Assets
CNY 2.9B
Cash
CNY 285.5M
Current Assets
CNY 1B
Current Liabilities
CNY 569.7M
Debt
CNY 217.6M
Debt EBITDA
CNY 0.68
Debt Equity
CNY 0.09
Debt FCF
CNY 3.84
Equity
CNY 2.3B
Liabilities
CNY 625.6M
Long Term Assets
CNY 1.9B
Long Term Liabilities
CNY 55.8M
Net Cash
CNY 67.9M
Net Cash By Market Cap
CNY 1.72
Net Debt EBITDA
CNY -0.21
Net Debt Equity
CNY -0.03
Net Debt FCF
CNY -1.2
Tangible Book Value
CNY 2.2B
Tangible Book Value Per Share
CNY 5.66
WACC
7.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.79
Inventory Turnover
7.49
Net Working Capital
CNY 382.1M
Quick ratio
1.11
Working Capital
CNY 451M
Working Capital Turnover
CNY 7.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-2.8%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
CNY 0.12
Dividend Years
14
Dividend Yield
1.16%
Ex Div Date
2025-07-03
Last Dividend
CNY 0.06
Payout Frequency
Annual
Payout Ratio
19.93%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-25.43%
1Y total return
1.15%
200-day SMA
10.1
3Y total return
25.68%
50-day SMA
10.17
50-day SMA vs 200-day SMA
50over200
5Y total return
-6.58%
All Time High
25.77
All Time High Change
-59.88%
All Time High Date
2020-08-13
All Time Low
4.63
All Time Low Change
123.33%
All Time Low Date
2024-02-08
ATR
0.3
Beta
0.57
Beta1y
0.4
Beta2y
0.38
Ch YTD
15.66
High
10.36
High52
13.4
High52 Date
2025-07-03
High52ch
-22.84%
Low
10.02
Low52
8.68
Low52 Date
2025-12-12
Low52ch
19.12%
Ma50ch
1.63%
Price vs 200-day SMA
2.37%
RSI
55.42
RSI Monthly
55.33
RSI Weekly
53.68
Sharpe ratio
0.78x
Sortino ratio
1.44
Total Return
-1.64%
Tr YTD
15.66
Tr15y
43.43%
Tr1m
6.05%
Tr1w
1.27%
Tr3m
-1.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 199.4M
Operating Income Growth
3.2
Operating Income Growth Q
20.82
Operating Income Growth3 Y
14.9
Operating Income Growth5 Y
32.48
Operating margin
7.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
282,631,722%
Net Borrowing
-134,600,000
Shares Insiders
8.94%
Shares Institutions
6.53%
Shares Out
380,567,380
Shares Qo Q
9.58%
Shares Yo Y
2.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
CNY 56.6M
Average Volume
8,766,443.1x
Bv Per Share
5.96
CAPEX
CNY -203.8M
Ch10y
-30.42
Ch15y
30.57
Ch1m
6.05
Ch1w
1.27
Ch1y
0.68
Ch3m
-1.9
Ch3y
21.65
Ch5y
-10.55
Ch6m
4.55
Change
2.78%
Change From Open
2.78
Close
10.06
Days Gap
0
Depreciation Amortization
118,500,694
Dollar Volume
111,859,164.3
Earnings Date
2026-04-25
EBIT
CNY 199.4M
EBITDA
CNY 317.9M
EPS
CNY 0.41
F Score
7
FCF
CNY 56.6M
FCF EV Yield
1.46x
FCF Per Share
CNY 0.15
Financing CF
-126,769,450
Fiscal Year End
December
Founded
1,997
Graham Number
7.43639
Graham Upside
-28.08
Income Tax
CNY 28.5M
Investing CF
-140,101,210
Is Primary Listing
1
Last Earnings Date
2026-04-25
Last Report Date
2026-03-31
Last Split Date
2014-06-09
Last Split Type
Forward
Lynch Fair Value
CNY 10.32
Lynch Upside
-0.22
Ma150
9.85
Ma150ch
5%
Ma20
10.17
Ma20ch
1.65%
Net CF
-12,239,294
Next Earnings Date
2026-08-27
Open
10.06
P FCF Ratio
69.49
P OCF Ratio
15.11
Payment Date
2025-07-03
Position In Range
94.12
Ppne
1,504,798,397
Price Date
2026-05-08
Price EBITDA
CNY 12.38
Ptbv Ratio
1.8
Relative Volume
1.27x
Revenue
2,814,072,432x
Tax By Revenue
1.01x
Tax Rate
15.59%
Tr6m
4.55%
Volume
10,818,101
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/002286 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.2%
$0.12 annual per share
Payout ratio
+19.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+9.6%
0 consecutive years of growth
Total shareholder yield
-1.6%
Next ex-dividend date: 2025-07-03
Performance

SHE/002286 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+1.2%
S&P 500 1Y: n/a
3Y total return
+25.7%
S&P 500 3Y: n/a
5Y total return
-6.6%
S&P 500 5Y: n/a
10Y total return
-25.4%
S&P 500 10Y: n/a
Ownership

Who owns SHE/002286?

Insider, institutional, and short-interest positioning.

Institutional ownership
+6.5%
Share of float held by funds and institutions
Insider ownership
+8.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.8%
Negative means the company is buying back shares.
Technical

SHE/002286 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.4
Neutral momentum band
Price vs 200-day MA
+2.4%
50/200-day relationship not available
Beta (5Y)
0.57
Less volatile than the market
Sharpe ratio
0.78
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/002286

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002286 stock rating?

she/002286 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002286 analysis?

The full report lives at /stocks/she/002286/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002286?

The latest report frames she/002286 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002286 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.